AppriseMD Blog
AppriseMD physician advisors overturned a denied inpatient stay for a myomectomy by discussing this procedure’s placement on the inpatient-only IPO list, which is for surgeries that are considered high risk. Even though the patient was discharged on the day of surgery, this reversal shows the importance of peer-to-peer discussions conducted by physician advisors with regulatory […]
White Papers

The financial impact of the IPO list magnified with the rise of CMS-4201-F, giving rise to inpatient reimbursement for all MAO patients who require services designated on the IPO list. Hospitals need to ensure that the proper setting is scheduled when any Medicare or MA patient undergoes a procedure designated on the IPO list, and they should also follow any proposed additions and removals to the list closely to ensure appropriate treatment and reimbursement.
Case Studies
THE CHALLENGE For hospitals, high-level severity denials are a major challenge resulting in increased administrative, clinical and financial burdens. One major concern is the dodging of the Two-Midnight rule, which was finalized under CMS-4201-F in April of 2023. The Two-Midnight rule sets the precedent that patients are appropriate for inpatient admission if the admitting physician […]
